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Evidence suggests a striking causal relationship between changes in quality control of
neuronal mitochondria and numerous devastating human neurodegenerative diseases,
including Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and amyotrophic
lateral sclerosis. Contrary to replicating mammalian cells with a metabolism essentially
glycolytic, post-mitotic neurons are distinctive owing to (i) their exclusive energetic
dependence from mitochondrial metabolism and (ii) their polarized shape, which entails
compartmentalized and distinct energetic needs. Here, we review the recent ﬁndings
on mitochondrial dynamics and mitophagy in differentiated neurons focusing on how the
exceptional characteristics of neuronal populations in their morphology and bioenergetics
needs make them quite different to other cells in controlling the intracellular turnover of
these organelles.
Keywords: mitochondria dynamics, quality control, mitophagy, primary neurons, neurodegenerative diseases
INTRODUCTION
Mitochondria exhibit dynamic properties (fusion, ﬁssion, trans-
port, biogenesis, and degradation) and their homeostasis in a
healthy, functional network is a process which involves an intimate
crosstalk between quality control and selective autophagy (Twig
et al., 2008;Westermann, 2012). All these events are closely coordi-
nated and reciprocally interact in an integrated system, constantly
monitored in every cell to maintain a well-performing mitochon-
drial population which can sustain a proper bioenergetic status
Abbreviations: AD, Alzheimer’s disease; Aβ, amyloid-β; ALS, amyotrophic lat-
eral sclerosis; Ambra1, activating molecule in Beclin-1-regulated autophagy 1;
AMPK, 5′-AMP-activated protein kinase; Atg, autophagy-related gene; BAX, Bcl-2-
associated X protein; CCCP, carbonyl cyanide m-chlorophenyl hydrazone; ClpXP,
caseinolytic peptidase XP; DJ-1/PARK7, Parkinson protein 7; Drp1, dynamin-1-like
protein; E3, ubiquitin ligase; ETC, electron transport chain; FIP200, focal adhe-
sion kinase (FAK) family interacting protein of 200 kDa; HD, Huntington’ disease;
HDAC6, histone deacetylase; HK, hexokinase activity; HSP90–Cdc37, heat shock
protein 90–cell division cycle 37; IDE, insulin-degrading enzyme; IMM, inner mito-
chondrialmembrane; iPS, induced pluripotent stem cell; KIF5, kinesin familymotor
protein 5; LC3, microtubule-associated protein 1A/1B-light chain 3; LIR, LC3 inter-
acting region; m-AAA, matrix-oriented AAA protease; Mfns1/2, mitofusins 1/2;
Miro,mitochondrial Rho GTPase 1; MMP,matrix metalloproteinase; mTOR,mam-
malian target of rapamycin; mTORC1, mTOR complex 1; mTORC2, mTOR com-
plex 2; NFR-1, nuclear respiratory factor 1; Nix, NIP3-like protein X; OCR, oxygen
consumption rate; OMM, outer mitochondrial membrane; OPA-1, optic atrophy 1;
OxPhos, oxidative phosphorylation; p97, AAA-ATPase (also called VCP for valosin-
and, consequently, viability. The quality control of mitochondria
relies on several different pathways, including: (i) degradation
of misfolded proteins located in the matrix and intermem-
brane space by intrinsic mitochondrial proteases; (ii) clearance
by ubiquitin–proteasome systems (UPS) of damaged proteins
located in outer membrane or of nuclear-coded mitochondrial
proteins which are not correctly imported; (iii) removal of
oxidated proteins/lipids by mitochondria-derived vesicles which
are directly targeted for lysosomal or peroxisomal degradation.
Besides, recent studies have uncovered a novel autophagic process
addressed selectively toward mitochondria and named mitophagy,
which is – up to date – the only identiﬁed mechanism by
which these defective and malfunctioning organelles are entirely
containing protein); PARL, presenilin-associated-rhomboid-like; PCs, Purkinje
cells; PD, Parkinson’s disease; PE, phosphatidylethanolamine; PGC-1α, peroxi-
someproliferator-activated receptorα coactivator; PI3K,phosphoinositide-3 kinase;
PI3P, phosphatidylinositol 3-phosphate; PIKK, phosphatidylinositol kinase-related
kinase; PINK-1, PTEN-induced putative kinase 1; Raptor, regulatory associated
protein of mTOR; RER, rough endoplasmic reticulum; ROS reactive oxygen species;
SMURF1, E3 ubiquitin-protein ligase; SQSTM1, sequestosome 1; TFAM, mito-
chondrial transcription factor A; TIGAR, TP53-induced glycolysis and apoptosis
regulator; TOM, translocase of the outer membrane; Ub, ubiquitin; UBA, ubiquitin
binding domain; ULK-1, UNC-51-like kinase 1; UPS, ubiquitin–proteasome sys-
tem; VCP, valosin containing protein; VDAC, voltage-dependent-activated channel;
Vps, vacuolar protein sorting.
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recycled or degraded. Remarkably, mitophagy can also play a key
physiological role by providing for the developmental matura-
tion of reticulocytes as well for the exclusive maternal inheri-
tance of mt DNA upon oocytes fertilization (Ding et al., 2012;
Ashraﬁ and Schwarz, 2013).
The classical regulation of autophagy is governed by the mam-
malian target of rapamycin (mTOR) pathway, which negatively
controls this process. The serine/threonine kinase mTOR belongs
to the phosphatidylinositol kinase-related kinase (PIKK) fam-
ily and is in charge of important intracellular processes such
as translation, metabolism, and transcription in response to
nutrients and/or growth factors (Sarkar, 2013). In mammalian
cells, mTOR binds several proteins to form two distinct pro-
tein multi-complexes. mTORC1 (mTOR complex 1) contains
the scaffolding protein Raptor and additional proteins that also
function in association with TOR in a second complex, called
mTORC2 (mTOR complex 2), that is not directly involved in
autophagy. mTORC1 is a key regulator of translation and ribo-
some biogenesis as well is responsible for autophagy induction
in response to starvation (Ghavami et al., 2014). On the other
hand, althoughbeing originally reported as rapamycin-insensitive,
mTORC2 is also likely targeted by this drug and is involved in the
regulation of phosphorylation and activation of Akt/PKB, pro-
tein kinase C, serum- and glucocorticoid-induced protein kinase
1. In addition, as Akt positively regulates mTORC1, it would
be possible that mTORC2 also acts as a negative regulator of
autophagy (Jung et al., 2010) Accumulating data also highlight
the crucial role of mTOR-dependent signaling pathways in neu-
rodegenerative diseases, including Huntington’s disease (HD),
Parkinson’s disease (PD), and Alzheimer’s disease (AD; Sarkar,
2013), as its pharmacological inhibition by rapamycin atten-
uates the accumulation of misfolded/aggregated proteins and
protects against neuronal loss, in vivo and in vitro (Ghavami
et al., 2014). Nevertheless, as compelling evidence demonstrate
that canonical non-selective autophagy and mitophagy share the
similar core autophagosome/mitophagosome initiation and for-
mation machinery (Hayashi-Nishino et al., 2009; Yoshii et al.,
2011), a two-step mitophagy model has been proposed to
occur in mammalian cells involving the initial induction of
autophagy-related genes (Atg)-dependent macroautophagy fol-
lowed by the mitochondrial priming. In the ﬁrst step, the
reactive oxygen species (ROS) accumulation and the ATP deple-
tion (indirectly via AMPK, AMP-activated protein kinase, acti-
vation) as result of damaged and dysfunctional mitochondria,
inhibit the induction of mTOR which under physiological con-
ditions blocks the autophagy by restraining the kinase activity
of ubiquitin-like kinase (ULK; Laplante and Sabatini, 2009;
Ghavami et al., 2014). Upon escaping from mTOR suppres-
sion, the ULK complex, including ULK-1 (mammalian Atg1
ortholog), Atg13, Atg101, and FIP200 promotes the de novo
formation of the initiation complex by regulating the activ-
ity of the class III phosphoinositide-3 kinase (PI3K) including
Beclin-1 (mammalian Atg6), Atg14, Ambra1 (activating molecule
in Beclin-1-regulated autophagy), vacuolar protein sorting 34
(Vps34), and Vps15, to form PI3P, which further recruits
several PI3P-binding proteins to drive the formation of the
initiation membrane. The Atg12–Atg5–Atg16L1 multi complex
and LC3 (microtubule-associated protein 1A/1B-light chain 3)–
PE (phosphatidylethanolamine) conjugates are later involved in
the elongation and closure of the initiation membrane (Itakura
and Mizushima, 2010; Feng et al., 2013; Sarkar, 2013). In
the second step, the priming of mitochondria is mediated by
different mechanisms that could be Parkin-dependent, involv-
ing the Parkin–Pink1-mediated pathway (Youle and Narendra,
2011), or Parkin-independent, involving the ubiquitin E3 lig-
ase SMURF1 (Orvedahl et al., 2011), the outer mitochondrial
membrane (OMM) protein Nix (Schweers et al., 2007; Sandoval
et al., 2008; Novak et al., 2010) and FUNDC1 (Liu et al., 2012a),
the HSP90–Cdc37 chaperone complex stabilizing and activating
ULK-1 (Joo et al., 2011) and the Atg9A/ULK-1 complex (Itakura
et al., 2012). An Atg-independent mitophagy, involving the 15-
lipoxygenase, has been also described (van Leyen et al., 1998) but
the precise role of this enzyme in organelles degradation is still not
completely clariﬁed.
Moreover, as the mitophagy pathway has been mainly studied
in non-neuronal cell lines, this process is still not fully clari-
ﬁed in terminally differentiated neurons. In polarized neurons
mitochondria have a longer half-life than in other post-mitotic
tissues (Menzies and Gold, 1971; Miwa et al., 2008; O’Toole et al.,
2008) and, although the translation of a subset of mitochondrial
proteins may occur in axons (Kaplan et al., 2009), the import
of most of those newly synthesized that are stably localized on
these organelles occurs in the cell body followed by their trans-
port toward distal axons, dendrites and synaptic sites. Removal
of damaged mitochondria is as well a bioenergetically demanding
task for neuronal populations because these organelles need to be
actively retro-transported to the cell body in order to fuse with
locally resident lysosomes (Wang et al., 2006). Besides, although
physiological aging has been associated with decreased mito-
chondrial functions and with mitophagic processes (Batlevi and
La Spada, 2011; Green et al., 2011), functional as well as mor-
phological impairment of these organelles – especially for those
neuronal populations with poorly myelinated, long, thin axons
located in selective brain areas (Verstreken et al., 2005) – have been
causally connected to several human neurological disorders (Lin
and Beal, 2006; Johri and Beal, 2012). An unbalanced turnover,
recycling/elimination of the entire mitochondria through selec-
tive autophagy is indeed considered an early event involved in
the pathogenesis of Charcot–Marie–Tooth (CMT) disease, PD,
AD, HD (Lin and Beal, 2006; Wang et al., 2009; Batlevi and
La Spada, 2011; Imai and Lu, 2011; Karbowski and Neutzner,
2012; Nunnari and Suomalainen, 2012; Sheng and Cai, 2012;
Chaturvedi and Beal, 2013; Itoh et al., 2013), amyotrophic lat-
eral sclerosis (ALS; Cozzolino and Carrì, 2012), cerebral ischemic
models (Calo et al., 2013), schizophrenia, and depression (Deheshi
et al., 2013). To this regard, it is worth mentioning that pato-
genetic and/or misfolded/aggregated proteins such as mutated
superoxide dismutase in ALS (Israelson et al., 2010), mutant hunt-
ingtin in HD (Rockabrand et al., 2007), β-amyloid (Aβ), and
tau in AD (Caspersen et al., 2005; Manczak et al., 2006; Hans-
son Petersen et al., 2008; Amadoro et al., 2010, 2012; Du et al.,
2012; Schmitt et al., 2012), mutant α-synuclein in PD (Devi
et al., 2008) in vivo accumulate on mitochondria causing their
functional decline which, in turn, may affect their mitophagic
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FIGURE 1 | Confocal microscopy of mature hippocampal neuronal
culture (15 DIV) double stained forTOMM20 (a mitochondrial marker;
green channel) and BrdU (for visualization of newly synthesized mito-
chondrial DNA; red channel). BrdU puncta colocalize with several TOMM20
positive mitochondria (arrows) in cell body, showing that biogenesis of these
organelles mainly occurs in perinuclear compartment. (A–C) Lower magniﬁ-
cation of TOMM20/BrdU immunoﬂuorescence. (D–F) Inset higher magniﬁ-
cation. (G–I) Colocalization analysis performed with ImageJ, including the
spatial pattern of colocalized points (G), the luminance intensity height of
the colocalized points (H), the spatial intensity proﬁle for both ﬂuorescence
channels (I) of the white line positioned in (F). Scale bar 15 and 5 μm. Figure
referring to data from Amadoro et al. (2014).
elimination (Moreira et al., 2007; Chinta et al., 2010; Choubey
et al., 2011; Amadoro et al., 2014; Figure 1). Furthermore, any
direct change in the mitochondrial biogenesis pathway [peroxi-
some proliferator-activated receptor α coactivator/nuclear respi-
ratory factor 1 (PGC-1α/NFR-1)] in neurons may also contribute
itself to accumulation of the above-mentioned pathogenetic pro-
teins at these organelles – affecting consequently their metabolic
functions – as recently shown for the long insulin-degrading
enzyme (IDE) isoform which is involved in mitochondrial Aβ
catabolism (Leal et al., 2013).
Interestingly, the relevance in assuring a proper quality control
of neuronalmitochondria clearly comes into view considering that
the mitochondrial dynamics which occur in a restricted hypotha-
lamic populations can exert systemic effects and contribute to
the physiological response of the whole-body energetic balance.
To this regard, two recent papers provide striking evidence that
alterations in mitochondrial number and morphology (Dietrich
et al., 2013) or in mitochondria–endoplasmic reticulum (ER) con-
nectivity (Schneeberger et al., 2013), both respectively occurring
in orexigenic [agouti-related peptide (Agrp)- and neuropeptide
Y (NPY)-producing] and antiorexigenic [pro-opiomelanocortin
(POMC)-producing] hypothalamic neurons, allow the metabolic
adaptation of feeding mice to different diet conditions.
In the present review, we focus on several speciﬁc and pecu-
liar aspects of the mitochondrial clearance mediated by the
Pink1–Parkin pathway in neurons and on the pathological impli-
cations that their inappropriate regulation may have in the onset
and/or progression of human neurodegeneration. Furthermore,
we will take advantage of the fact that a growing body of informa-
tion on the mechanisms involved in mitophagy in non-neuronal
cells has been extensively reported by other authors (Detmer and
Chan, 2007; Palmer et al., 2011; Wang and Klionsky, 2011; Ashraﬁ
and Schwarz, 2013).
REGULATION OF MITOCHONDRIAL DYNAMICS AND
BIOENERGETIC STATUS IS OF PARTICULAR RELEVANCE TO
POST-MITOTIC NEURONS
The mitochondria quality control regulates in post-mitotic neu-
rons several vital metabolic functions such as their proper distri-
bution to synaptic terminals, maintenance of electron transport
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chain (ETC) activity and electrical connectivity (Stowers et al.,
2002; Verstreken et al., 2005; Chen and Chan, 2006; Liu and
Shio, 2008; Bereiter-Hahn and Jendrach, 2010; Ferree and Shir-
ihai, 2012; Misko et al., 2012), protection of mtDNA integrity
(Westermann, 2002; Parone et al., 2008), apoptosis (Suen et al.,
2008), formation and function of synapses and dendritic spines
(Li et al., 2004). As other cell types, neuronal populations also con-
tinually modulate size and number of these organelles, according
to the variable energy demands and metabolic states through-
out the entire lifetime and/or different sub-cellular compart-
ments (Chen and Chan, 2009; Santos et al., 2010; Vives-Bauza
and Przedborski, 2011; Van Laar and Berman, 2013). How-
ever, a tight control of the interplay between their mitochondrial
dynamic and bioenergetic status is of particular relevance for
post-mitotic neurons because they have a unique metabolic as
well as morphological proﬁle which entails specialized and com-
partimentalized energetic needs. Indeed, neuronal populations
are typically characterized by: (i) high bioenergetic needs as the
ATP production classically depends in these cells on OxPhos res-
piration rather than glycolysis (Rolfe and Brown, 1997; Attwell
and Laughlin, 2001; Mironov, 2009; Bolanos et al., 2010); (ii) a
very polarized morphology with extensive neuritic projections
which are crucial for neuronal survival via a proper mainte-
nance of their mitochondrial biomass. Remarkably, although
the human brain consists of only 2% of the volume of the
body, it is roughly responsible for 25% of net oxygen consump-
tion in resting conditions (Magistretti and Pellerin, 1999) with
neurons generating as much as 95% of their ATP exclusively
from mitochondrial OXPhos (Erecin´ska et al., 1994). However,
it is worth noticing that neurons and astrocytes – which are
the two major types of brain cells – exhibit a different pref-
erence for glucose utilization since its metabolism in neuron
is diverted mainly to the pentose phosphate pathway in order
to regenerate antioxidants (reduced glutathione) and to pro-
mote survival (Bolanos et al., 2010). As they constantly require
an active and efﬁcient defense mechanism against oxidative
stress (Almeida et al., 2005; Herrero-Mendez et al., 2009), neu-
ronal populations are indeed unable to switch to anaerobic
glycolytic metabolism (as an ATP-generating mechanism) during
an acute mitochondrial stress, relying on lactate as an alternative
substrate for their mitochondria-derived bioenergetic purposes
(Pellerin et al., 2007). In addition, it is generally assumed that
only 0.2% of the neuronal cellular volume is in the cytoplas-
mic soma while about 99.8% is constituted by the axonal and
dendritic compartments (Devor, 1999; Fjell and Walhovd, 2010;
Florenzano, 2012). For instance, the axonal length of projec-
tion neurons – such as those of rat dopaminergic neurons that
are localized in the substantia nigra which is an area selec-
tively affected in PD – can be as long as 470 μm or more
and can provide several axon collaterals each of them mak-
ing in turn contacts with approximately 400 synapses (Matsuda
et al., 2009). Besides, in order to locally provide ATP supply
and calcium buffering required for the neuronal activity of high
energy-demanding terminal synapses (Schon and Przedborski,
2011), an high number of mitochondria resides far away from
soma being localized in distal axon and dendritic processes
(Hollenbeck, 2005) such as presynaptic terminals, including
the active zones where synaptics vesicles (SVs) are released
(Rowland et al., 2000; Perkins et al., 2010), post-synaptic den-
sities, nodes of Ranvier and in growth cones (Fabricius et al.,
1993; Morris and Hollenbeck, 1993). Collectively, such pecu-
liar requirements imply that a high number of mitochondria
spend the majority of their time in traveling up-and-down
between the sites of their biogenesis, which are mainly local-
ized into cell bodies (Davis and Clayton, 1996; Saxton and
Hollenbeck, 2012; Figure 2), and those of their functional uti-
lization which instead are close to terminal endings (Li et al.,
2004). Interestingly there’s a positive correlation between the
frequency and/or the intensity of synapse electrical activity and
the number of metabolically active mitochondria at presynap-
tic compartment (Dubinsky, 2009). Furthermore, provided that
the mitochondria size and mass are not the same for all neu-
rons (Dubinsky, 2009; Lu, 2009) and that intrinsic mitophagic
capacity has been found to be brain region-speciﬁc (Diedrich
et al., 2011), any perturbation in controlling the dynamics prop-
erties of these organelles (Verstreken et al., 2005; Kann and
Kovács, 2007; Nunnari and Suomalainen, 2012) can seriously and
selectively compromise their survival (Xue et al., 2001). Differ-
ent morphologies and ultrastructural proﬁles of mitochondria
have been also correlated with distinct bioenergetic demands of
the tissues they occupy and mitochondrial network in neurons
is demonstrated to be distinct from those of other tissues in
morphology, interconnectivity as well as cytoplasmatic pattern
distribution (Dubinsky, 2009; Kuznetsov et al., 2009; Mironov,
2009). Neurons critically depend on autophagy for differenti-
ation and survival (Komatsu et al., 2006) and are particularly
prone to autophagic stress (Chu, 2006) so that basal autophagy
appears to be more efﬁcient than in other proliferating non-
neuronal cells types (Boland et al., 2008) and is also likely to
be regulated in alternative and quite different ways (Ashraﬁ and
Schwarz, 2013; Van Laar and Berman, 2013). Being terminally
differentiated and producing high levels of ROS against rela-
tively fewer antioxidant molecules (Cui et al., 2004; Fatokun et al.,
2008), neurons need to refurbish “old” mitochondrial pool to
prevent the deleterious accumulation of oxidative damage, as
suggested by the fact that antioxidant treatment supports the sur-
vival of cerebellar Purkinje cells (PCs) from knockout mice for
dynamin-1-like protein (Drp1) ﬁssion protein (Kageyama et al.,
2012). In contrast, proliferating cells constantly generate “new”
mitochondria during continuous cell replication cycles so that
oxidative stress may be diluted and maintained at relatively low
levels, even without any mitochondrial division (Kageyama et al.,
2012). A proper interplay between the bioenergetic – which is
mainly regulated by energy requirement and substrate availabil-
ity – and the mitochondrial quality control and autophagy –
which control the overall health of mitochondrial population
and their relative abundance – is speciﬁcally critical in neu-
rons as it impinges on their intrinsic resistance to stress and,
then, on their survival. Indeed, the relative sensitivity of differ-
ent neuronal populations to mitochondrial inhibitors is tightly
correlated with their “spare respiratory capacity,” which is an
index of general mitochondrial health taking into account the
ratio of the glucose utilization rate to the expression level
of respiratory chain complexes (Fern, 2003). Interestingly, the
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FIGURE 2 | Confocal microscopy and image analysis of double
immunofluorescence for cyt C (a mitochondrial marker; green
channel) and LC3 (for visualization of autophagosomes; red
channel), carried out on primary mature hippocampal cultures
(15 DIV) at 12 h post-infection (MOI 50) with mock- and myc-NH2
26-230 human tau vectors. Nuclei were stained with DAPI (blue
channel). (A–C) Numerous labeled LC3 stained vesicles intensely posi-
tive (colocalized) for cyt C were observed in myc-NH2htau neurons.
Arrows point to two large mitophagosomal structures. (G–I) LC3
immunoﬂuorescence is very faint in mock-treated cultures (D–F); (J–L)
colocalization analysis performed with ImageJ, including the spatial
pattern of colocalized points of (D,J), the intensity height of the
luminance in the colocalized points (E,K), the spatial proﬁle of the
ﬂuorescence intensity for both ﬂuorescence channels for the white line
positioned on several mitophagosomes in the second row (F,L). Scale
bar 7 μm. Figure referring to data from Amadoro et al. (2014).
vulnerability to a complex I inhibitor such as rotenone of cultured
striatal neurons, which are selectively affected in HD pathology,
is primarily determined by their “spare respiratory capac-
ity” rather than oxidative stress (Yadava and Nicholls, 2007).
Likewise, presynaptic mitochondria from hippocampus and
cortex show a lower spare respiratory capacity to rotenone
when compared to non-synaptic mitochondria from the same
regions (Davey et al., 1997), in favor with the ﬁnding that
the bioenergetic failure of peripheral mitochondria in vivo
initiates the loss of synaptic terminals in neurodegenerative
diseases.
Nevertheless, despite the regulation of the physiological mito-
chondrial turnover is of particular importance for neuronal popu-
lations, it is not completely clear, as yet, whether an up-regulation
or a down-regulation of mitophagic processes accompanied to an
uncoordinated biogenesis can critically contribute to the onset
and/or progression of human neurodegeneration (Batlevi and La
Spada, 2011; Zhu et al., 2012, 2013).
THE PINK/PARKIN PATHWAY IN NEURONS: ENERGETIC
METABOLISM, NATURE, AND SEVERITY OF INJURY DICTATE
THE REGULATION OF MITOCHONDRIAL DEGRADATION IN
MATURE NEURONS
The Pink/Parkin pathway involves the interplay of two recessive
Parkinson’s-linked genes PTEN-induced kinase 1 (PINK1) – a
mitochondrially targeted serine/threonine kinase – and Parkin –
an E3 ubiquitin ligase – which cooperate in maintaining the
mitochondrial integrity by regulating several physiological pro-
cesses of these organelles, including their membrane poten-
tial, calcium homeostasis, cristae structure, respiratory activity,
and mtDNA integrity (Trempe and Fon, 2013). In addition,
the Pink/Parkin pathway is crucial for autophagy-dependent
clearance of dysfunctional mitochondria (Narendra et al., 2008;
Matsuda et al., 2010; Figure 3) as, in the absence of PINK1 or
Parkin, cells often develop fragmented mitochondria (Büeler,
2010). Speciﬁcally, in mammalian cells, cytosolic Parkin is
selectively recruited to dysfunctional, depolarized mitochondria
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FIGURE 3 | Cartoon illustrating steps in the mitochondrial clearance
mediated by the Pink1–Parkin pathway. (A) In physiological conditions,
Pink-1 is constitutively imported into healthy mitochondria via TIM/TOM
complex to the inner membrane (IMM), cleaved by presenilin-associated
rhomboid-like protease (PARL), and then proteolytically degraded. (B) Upon
 collapse, full-length Pink1 is not processed accumulating at the outer
membrane (OMM) to recruit Parkin onto depolarized mitochondria. PINK1
autophosphorylation at Ser228 and Ser402 (P) is essential for efﬁcient
mitochondrial localization of Parkin. The PINK1-dependent Parkin phos-
phorylation at Ser65, combined with unknown factor(s) (?), is required not
only for its efﬁcient translocation but also for the degradation of mito-
chondrial proteins during mitophagy. (C) After being recruited on OMM,
Parkin triggers mitophagy by ubiquitylating (Ub, K48, K63) several proteins
including Mfns1/2, VDAC, TOM. Proteasome-mediated removal of Mfns1/2
not only inhibits mitochondrial fusion but also prevents its default rear-
(Continued)
FIGURE 3 | Continued
rangement into spheroids, allowing thus the damaged organelles to be
recognized by the engulﬁng autophagosome. Cytosolic autophagy adaptor
p62 (also known as sequestosome 1, SQSTM1) is also involved in mito-
phagy as its K63-ubiquitin-binding domain (UBA) as well as an LC3- binding
domain (LIR), recruits autophagosomes to ubiquitylated protein. For more
information on Pink–Parkin-dependent mitophagy, please refer to recent
excellent reviews (Twig and Shirihai, 2011; Vives-Bauza and Przedborski,
2011; Youle and Narendra, 2011; Ding andYin, 2012; Jin andYoule, 2012).
Freely adapted from Figure 6 of (Okatsu et al., 2012).
upon dissipation of ψm by chemical uncoupler CCCP (car-
bonyl cyanide m-chlorophenyl hydrazone), then promoting their
autophagic-lysosomal-mediated degradation. The Parkin translo-
cation to depolarized mitochondria requires the activity of PINK
which – in basal conditions – constantly undergoes a ψm-
dependent import into these organelles followed by speciﬁc
maturation mediated by intrinsic protease(s), including matrix
metalloproteinase (MMP), presenilin-associated-rhomboid-like
(PARL),matrix-orientedAAAprotease (m-AAA), and caseinolytic
peptidase XP (ClpXP). Conversely, in response to low potential,
full-length PINK is not imported/cleaved but rapidly stabilized,
accumulating thus on outer membrane TOM (translocase of
the outer membrane) complex (Batlevi and La Spada, 2011;
Ashraﬁ and Schwarz, 2013; Grenier et al., 2013) where it engages
Parkin which, in turn, triggers the mitochondria deliver toward
autophagic-lysosomal pathway. Pink indeed recruits, directly or
indirectly, Parkin from cytosol in close proximity on depolar-
ized mitochondria and critically promotes its E3 ubiquitin ligase
activity, likely by Ser65-phosphorylation, in the initial step of
mitophagy (Kondapalli et al., 2012; Shiba-Fukushima et al., 2012;
Iguchi et al., 2013). Parkin recruitment to mitochondria induces
ubiquitination of several targets such as mitochondrial fusion
proteins mitofusins (Mfns1/2) and voltage-dependent-activated
channel (VDAC; Gegg et al., 2010; Geisler et al., 2010) whose
proteasomal degradation (Chan et al., 2011; Yoshii et al., 2011)
provokes the fragmentation of the organelle followed by its
engulfment by autophagosomes (Deas et al., 2011). In addition
p97, an AAA+ATPase, also accumulates on mitochondria in a
Parkin-dependent manner to promote the degradation of OMM
proteins and thenmitophagy (Tanaka et al., 2010). Concerning the
role of Parkin-mediated ubiquitination of Mfns1/2 in promot-
ing mitophagy, two different but not mutually exclusive models
have been proposed. To start with, the degradation of Mfns1/2 by
UPS might disperse the clustered mitochondria and facilitate their
engulfment by autophagosomes (Chan et al., 2011). Secondly, the
removal of this pro-fusion mitochondrial protein shifts the bal-
ance toward the fragmentation – which is crucial in triggering
mitophagy (Twig et al., 2008) – likely by physically interfering with
the formation of Mfns1/2 trans-homodimers needed for tethering
of these organelles (Ziviani and Whitworth, 2010). Alternatively,
Parkin-mediated degradationmight remove several negative regu-
lators localized on the mitochondrial surface, thereby unmasking
a molecular signal for recruitment of depolarized mitochondria
by autophagosomes (Chan et al., 2011). Interestingly, the Parkin-
induced elimination of Mfns1/2 is necessary for mitophagy to
occur as it prevents the activation of an inhibitory default path-
way in which depolarized and fragmented mitochondria undergo
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a drastic conformational change to become large spheroids that
are not recognized by autophagosomes (Ding et al., 2012).
A large number of studies performed in non-neuronal cells
lines have demonstrated that PINK1/Parkin pathway affects the
autophagy clearance of damaged mitochondria in several ways:
(i) by shifting the balance between fusion and ﬁssion of the
mitochondrial network, allowing fragmented mitochondria to be
taken up in autophagic vesicles; (ii) by modulating mitochon-
drial motility in order to switch the movement of mitochondria
toward the autophagosome- and lysosome-rich perinuclear area,
where the probability of being taken up by autophagosomes [AVs
(autophagic vacuoles)] is higher and (iii) by directly recruiting the
autophagic machinery to damaged mitochondria (de Vries and
Przedborski, 2013). Neuronal mitochondria also undergo con-
tinuous reshaping by paired ﬁssion/fusion, transport, biogenesis,
and selective degradation (Vives-Bauza et al., 2010; Fischer et al.,
2012; Sheng and Cai, 2012; Youle and van der Bliek, 2012), as in
immortalized cells lines (Youle and Narendra, 2011). Experimen-
tal data have indeed proved that PINK1/Parkin pathway regulating
the mitochondrial quality control is active in primary neurons, as
in replicating cell types (Seibler et al., 2011; Van Humbeeck et al.,
2011; Yu et al., 2011; Cai et al., 2012; Joselin et al., 2012; Koyano
et al., 2013; McCoy et al., 2014). However, other studies carried
out in vitro (Van Laar et al., 2011; Rakovic et al., 2013) as well as
in vivo (Sterky et al., 2011; Yu and Lu, 2011; Lee et al., 2012;Vincow
et al., 2013) have yielded controversial results concerning the actual
existence of mitophagy in neurons, especially those regarding the
recruitment of Parkin to dysfunctional mitochondria. Indeed, in
HeLa and MEF (mouse embryonic ﬁbroblast) cell lines a gen-
eral depolarization induced by pharmacological treatment with
the uncoupler CCCP or other mito-toxins – such as antimycin A,
valinomycin, and rotenone known to be ETC inhibitors – results
in a rapid, robust, and faithfully reproducible re-localization of
Parkin to mitochondria, followed by their prolonged and selec-
tive autophagic clearance (Narendra and Youle, 2011; Youle and
Narendra, 2011; Ding and Yin, 2012; Youle and van der Bliek,
2012; Ashraﬁ and Schwarz, 2013). Likewise, immortalized cybrid
cell lines carrying lethalmtDNAdeletion –which causes a dysfunc-
tional ETC assembly with decreased membrane potential – have
also been shown to exhibit mitochondrial recruitment of Parkin at
the beginning of mitophagy (Gilkerson et al., 2012). Conversely, in
cultured primary neurons, a frank depolarization-evoked translo-
cation of Parkin to mitochondria appears to be more variable.
Discrepancies on (i) different type, handling and culture con-
ditions (caspase(s) inhibitor, glial layer, antioxidant B27) used;
(ii) expression of endogenous physiological level of proteins or
transfection of exogenous transgenes; (iii) cell type-speciﬁc bioen-
ergetic proﬁle; (iv) type of injury and duration of treatment are
indeed all important features that should be taken into account
in evaluating studies on mitophagy mechanisms undergoing in
post-mitotic neurons. As further discussed, the mitophagy path-
ways has turned out to differ – both spatially and kinetically – in
cultured primary neurons from those found in immortalized lines
(Table 1) and, perhaps, it might also diverge in its physiological
function of removal of dysfunctional mitochondria.
To this regard, the recruitment of endogenous Parkin to depo-
larized mitochondria has been ﬁrst provided by Narendra et al.
(2008), showing that an enhanced immunoreactivity level of
Parkin is found by Western blotting on crude mitochondria-
enriched fractions from rat cortical neurons treated for 1 h with
CCCP, although its increase is not as much signiﬁcant as in
HEK293 (human embryonic kidney 293) cells exposed to similar
experimental conditions. Afterward, another paper (Vives-Bauza
et al., 2010) has proved that this event is strictly Pink-1 depen-
dence since the CCCP-induced collapse of m for 1 h is not
longer associated with an endogenous relocalization of Parkin to
mitochondria in primary neurons from PINK1 (−/−) mice, as
well as in PINK1 – siRNA silenced HeLa cell line. More recently
another group (Wang et al., 2011) reports that, as in non-neuronal
HEK293T cells, treatment up to 1 h with a complex III inhibitor
such as antimycin A also induces in cultured rat hippocampal
neurons the translocation of exogenously expressed YFP-Parkin
on axonal mitochondria, signiﬁcantly decreasing their size and
shape. In contrast, no evidence of a frank translocation of overex-
pressed as well as endogenous Parkin has been found to occur,
neither in distal axons and dendrites nor in cell bodies mito-
chondria, in primary cortical neurons when they are acutely
depolarized with CCCP up to 6 h, regardless of a clear evi-
dence of active mitophagic pathway in these in vitro cultures
(Van Laar et al., 2011). In agreement with the dispensable role
of Parkin in degrading damaged mitochondria in vivo, overex-
pressed Parkin-independent accumulation and/or elimination of
these organelles are allowed to occur in dopaminergic neurons
of MitoPark mice carrying a severe respiration dysfunction due
to their DNA (mtDNA) loss in mitochondrial transcription fac-
tor A (TFAM; Sterky et al., 2011). However, only recently, it has
been clearly shown that the neuronal mitophagic response to an
acute, excessivemitochondrial stressor is a process not only tempo-
rally slow but also spatially regulated (Cai et al., 2012). Compared
with non-neuronal cells, CCCP-induced translocation of Parkin
rarely occurs in mature neurons within 6 h and Parkin ring-
like structures surrounding fragmented mitochondria are only
occasionally detectable as early as 12 h of treatment, becoming
increasingly frequent only at 18 h. In addition, the gradual and
delayed Parkin recruitment to neuronal mitochondria (i) is com-
partmentally restricted to the somatodendritic regions and (ii)
is coupled to reduced anterograde transport of these damaged
organelles ending in an efﬁcient lysosomal degradation into soma
after 24 h exposure to CCCP (Cai et al., 2012). Interestingly, the
fact that CCCP exposure does not initiate Parkin translocation
and/or mitophagy in primary neurons up to 6 h might be in part
explained because this process is regulated, to some extent, by
bioenergetics dynamics since mammalian cells with a metabolism
essentially glycolytic – if forced into OxPhos respiration – also
recapitulate these effects, in a similar way of terminally differen-
tiated neurons (Kanki and Klionsky, 2008; Van Laar et al., 2011).
Indeed when glucose-fed HeLa cells were compelled to rely on
mitochondrial oxidative phosphorylation in galactose/glutamine
media – a culturing condition mimicking neuronal metabolism
because it favors utilization of the citric acid cycle and oxida-
tive phosphorylation over lactic acid-generating glycolysis for
ATP production – they failed to recruit Parkin to their mito-
chondria upon CCCP-depolarization (Van Laar et al., 2011). The
ﬁnding that Parkin translocates to depolarized mitochondria in
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Table 1 | Comparison of Pink–Parkin pathway between immortalized cells and post-mitotic neurons.
Immortalized
cells*
Primary neurons
(iPS-derived neurons)
bibliography
Dependence on ATG family proteins Yes Yes Cai et al. (2012)
Pink-dependence Yes Yes Vives-Bauza et al. (2010), Seibler et al. (2011), Joselin et al.
(2012), Rakovic et al. (2013), McCoy et al. (2014)
 Loss Yes Yes Joselin et al. (2012), Koyano et al. (2013)
Meantime of Parkin recruitment upon 
depolarization
30 min 4 h
12 h
6 h
24 h
Joselin et al. (2012), Van Laar et al. (2011),
Seibler et al. (2011), Cai et al. (2012)
% cells with Parkin recruitment 90% 25%
30%
45%
70%
McCoy et al. (2014), Cai et al. (2012), +ZVAD,
Koyano et al. (2013), Joselin et al. (2012), no B27
Ubiquitination of mitochondria prior mitophagy Yes Yes Joselin et al. (2012), Koyano et al. (2013)
Smaller mitochondria size and perinuclear
clustering
Yes Yes Yu et al. (2011), Cai et al. (2012)
Loss of mitochondria Yes No Van Laar et al. (2011), Yu et al. (2011), Rakovic et al. (2013)
Endogenous Parkin recruitment Yes ? Cai et al. (2012), Rakovic et al. (2013)
Ambra1 Yes ? Van Humbeeck et al. (2011), coIP Ambra1/Parkin
Hexokinase 2 Yes Yes McCoy et al. (2014)
*HeLa, HEK293T, SH-SY5Y, MEFs.
glycolytic HeLa cells, which are grown in glucose-based media,
but not in HeLa cells forced to rely on mitochondrial respiration,
being grown in glucose-free media supplemented with galac-
tose/glutamine, clearly shows that the induction of mitophagy is
prevented by augmenting the cellular energy dependence on mito-
chondrial metabolism (Van Laar et al., 2011). Further, neither a
robust association of overexpressed Parkin with mitochondria nor
co-localization of these organelles with autophagic LC3 marker
are clearly detected in cortical primary neurons at 1 h even after
co-treatmentwith anETC inhibitor sucholigomycinwhich, block-
ing the reverse hydrolysis activity of mitochondrial ATP synthase,
enable these in vitro cultures to temporarily hinder the massive
energetic ATP drop caused by the CCCP-induced depolariza-
tion. Then again, the ATP loss induced by CCCP-depolarization
is not the sole determinant in the inhibited Parkin transloca-
tion to mitochondria – and consequently in the induction of
mitophagy – in oxidative phosphorylation-dependent neurons
when compared to glycolytic HeLa cell lines (Van Laar et al.,
2011). In view of these ﬁndings, it has been proposed that (i)
the Parkin response is markedly suppressed in primary neurons
in contrast to HeLa cells and that (ii) the rapid loss of ATP
after a wide mitochondrial insult may prevent in neurons the
full-scale Parkin-associatedmitophagy,whichmaybequite impor-
tant in conditions of slowly accumulating damages such as in
aging-related human neurodegeneration. However, it is worth
mentioning that even after 24 h, a selective damage to a small
pool of mitochondria may still allow mitophagy processes since
Parkin recruitment is seen in roughly 26.7% of neurons (Cai et al.,
2012). Surprisingly, a restricted population of these mitochon-
dria shows evidence of partial recovery of membrane potential –
even after a prolonged depolarization induced by 24 h CCCP
exposure – suggesting that a few, delayed bioenergetic compen-
satory changes occurring in primary neurons may yet permit these
organelles to undergo elimination via autophagy (Cai et al., 2012).
Finally a rapid (4 h) Parkin relocalization to mitochondria has
been established to occur in mouse cortical neurons by exposing
these cultures to a variety of mitochondrial damaging agents [i.e.,
CCCP, MPP+ (1-methyl-4-phenylpyridinium), and rotenone] in
the absence of antioxidants, which are normally present in sup-
plement B27 medium known to be routinely added to culturing
medium of primary neuronal cultures. To this regard and consis-
tently with a critical role of ROS in regulation of mitochondrial
quality control, Joselin et al. (2012) report that mitochondrial
translocation of Parkin is a ROS-dependent process in neurons
because treatments with several ROS blockers can prevent at 6 h
the recruitment of its overexpressed form in these cultures (as
well as in MEFs). In addition, the same authors show that the
loss of DJ-1 – a gene which is assumed to be critically linked
to ROS management – can also trigger an accelerated stress-
induced recruitment of Parkin to mitochondria facilitating thus
their autophagic elimination via mitophagy. These ﬁndings not
only undoubtedly conﬁrm the active presence of Parkin/PINK1-
mediated pathway in quality control of neuronal mitochondria
but also (i) indicate that neuronal culturing conditions containing
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antioxidant supplements can prevent the pharmacologic effect
of mitochondrial uncouplers and (ii) provide a possible expla-
nation of the why several groups (Van Laar et al., 2011) are not
able to detect signiﬁcant Parkin translocation in neurons upon
CCCP-depolarization. Interestingly TIGAR (TP53-induced gly-
colysis and apoptosis regulator), a biphosphatase which lowers
the intracellular level of fructose-2,6-biphosphate (Fru-2,6-P2)
with consequent inhibition of glycolysis and an overall decrease
of intracellular ROS via increased production of NADPH through
the pentose phosphate shunt, has also been recently identiﬁed
as a novel negative regulator of neuronal mitophagy. In fact,
antisense-mediated inactivation of TIGAR induces a complete
normalization of impaired mitochondrial metabolism (morphol-
ogy, complex I and III activity) in pink−/− zebraﬁsh with ensuing
rescue of dopaminergic neurons, suggesting that the manipula-
tion of its physiological level can be a promising novel target
for disease-modifying therapy in PINK1-related PD (Flinn et al.,
2013). Finally, in favor with the proposal that the Pink1/Parkin is
dependent on bioenergetic status (Van Laar et al., 2011), an ele-
gant paper has recently reported that the apparent discrepancy in
depolarization-induced relocalization of Parkin to mitochondria
of primary neurons could be ascribed to their different amount
of hexokinase activity (HK), an enzyme which catalyzes the con-
version of glucose to glucose-6-phosphate. In agreement with
their previous experiments in HeLa cells, McCoy et al. (2014) ﬁnd
that overexpression of wild-type but not kinase-inactive HK2 pro-
motes the increase in mitochondrial translocation of overxpressed
Parkin upon 6 h CCCP-depolarization, even in the presence of
B27 in culturing medium. Data from these authors show in
fact that (i) the activity of glycolytic hexokinase is upstream of
Pink-1 and is crucial for recruitment of overexpressed Parkin to
mitochondria in cortical primary neurons upon 6 h treatment
with CCCP, acting thus as a modiﬁer of Parkin relocalization to
these organelles; (ii) the Parkin relocalization to mitochondria
in these cultures in response to depolarizing conditions requires
both ATP synthesis and active Pink1 signaling (McCoy et al.,
2014).
An important point that needs also to be taken into account is
that the type of insult may also impose the outcome of neuronal
response to mitophagy. The mitochondrial complex III inhibitor,
antimycin A, has been recently reported to trigger, up to 1 h,
a rapid relocalization of Parkin to axonal mitochondria in pri-
mary rat hippocampal neurons (Wang et al., 2011). Conversely, in
the same experimental conditions of overexpression and presence
of B27, a retarded and sometimes insigniﬁcant Parkin-associated
mitophagy has been described to occur at 12–24 h upon CCCP-
depolarization throughout the whole neuronal body, including
the soma and axonal compartments (Van Laar et al., 2011), or
only in cell bodies and in dendrites but not in axons (Cai et al.,
2012). Contradictory results in dopaminergic neurons derived
from induced pluripotent stem cell (iPS) cells have also showed
that, although recruitment of both endogenous and overexpressed
Parkin to mitochondria is detectable in these in vitro cultures after
12 h exposure to another agent depolarizing such as valinomycin,
this translocation is accompanied by no signiﬁcant degradation of
mitochondrial proteins located at the outer or inner membranes
and at the matrix in contrast to a net reduction in mitochondrial
DNA copy numbers (Seibler et al., 2011; Rakovic et al., 2013). To
start with, it is worth noticing that a prolonged incubation with a
chemical uncoupler in absence of caspase inhibitors – whose usage
is conversely advised by Cai et al. (2012) – may promote apoptosis
in these cultures. Secondly, the bioenergetics of cultured differen-
tiated iPS cells requires still to be fully analyzed as it might be more
different from that of primary neurons. Interestingly, in addition
to adiminishedordelayed translocationof Parkin tomitochondria
in response to depolarizing CCCP, neurons show also a different
temporal threshold for commitment of mitophagy in compari-
son to immortalized cell lines. In fact, it has very recently been
demonstrated that redistribution of the cardiolipin from inner
mitochondrial membrane (IMM) to OMM of damaged mito-
chondria can act as signal in cargo selection for their autophagic
elimination and that injured neurons exhibit a larger percentage in
membrane externalization of this phospholipid when compared
to CCCP-treated HeLa cells (Chu et al., 2013).
However, it’s noteworthy that Parkin can regulate the mito-
chondrial physiology in neurons along different ways which are
beyond their selective elimination via autophagy and do not
necessarily require its stable recruitment to them such as (i) pro-
moting their biogenesis (Shin et al., 2011) and optic atrophy 1
(OPA-1)-dependent integrity (Müller-Rischart et al., 2013) via
activation of nuclear transcription factors; (ii) controlling their
axonal trafﬁcking (Wang et al., 2011; Liu et al., 2012b); (iii) sup-
pressing apoptosis via Bax ubiquitination (Johnson et al., 2012);
(iii) regulating the selective turnover of respiratory chain proteins
(Vincow et al., 2013), likely by chaperone-mediated extraction
followed by proteasomal degradation (Margineantu et al., 2007)
and/or by direct transport of selected cargo to lysosomes through
mitochondria-derived vesicles (Neuspiel et al., 2008; Soubannier
et al., 2012).
THE PINK/PARKIN PATHWAY IN NEURONS: MORPHOLOGY
AND AXONAL TRANSPORT OF MITOCHONDRIA,
NUCLEATION OF NEW PHAGOPHORES THROUGH DIRECT
Ambra1 RECRUITMENT ON MITOCHONDRIA
As far as the role of PINK1/Parkin pathway on mitochondrial
morphology in neurons, evidence have demonstrated that PINK1
knock-down leads to elongation of mitochondria in rat hip-
pocampal as well as in dopaminergic primary cultures while
overexpression of either PINK1 or Parkin results in an increased
number of mitochondria that are smaller in size (Yu et al., 2011).
Quite the opposite, studies carried out in cell lines such as HeLa
(Exner et al., 2007), SH-SY5Y (Lutz et al., 2009; Dagda et al., 2011),
and N27 (Cui et al., 2010) have reported that mitochondria are
found to be fragmented upon knock-down of PINK1 or Parkin
and that this fragmentation is likely to be the result of an excessive
ﬁssion because it is accompanied by an increase in mitochon-
drial ﬁssion proteins paralleled by an inverse decrease in their
fusion proteins (Cui et al., 2010). However, no useful information
are further provided by data from PD patient-derived ﬁbroblasts
carrying the PINK1Q126P or PINK1G309D pathogenic mutations
which show no evident and signiﬁcant changes in mitochondria
morphology, although there is a slight tendency toward frag-
mentation in comparison with related control subjects (Exner
et al., 2007). Nevertheless, a recent paper (Cronin-Furman et al.,
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2013) reports that the expression of three PD patients-derived
mitochondrial DNAs in independent lines of cytoplasmic hybrid
(cybrid) neural cells can provoke differential effects on mitochon-
drial morphology (from rod-like to swollen, fragmented, and
globular shape), on movement of these organelles along axonal
processes and on their oxygen consumption, assessed as basal
measurements of oxygen consumption rate (OCR). Furthermore,
neurons are able to activate pathways that affect mitochondrial
mitophagy differently from those operating in replicating, non-
neuronal cultures, even if in response to an identical insult.
Indeed, when primary cortical neurons are exposed for 12 h to
camptothecin in order to mimic the chronic genotoxic oxida-
tive stress occurring in neurodegenerative diseases (Lin and Beal,
2006), a signiﬁcant mitochondrial elongation with a suppressed
expression of ﬁssion protein Drp1 and Parkin is clearly detectable
in these in vitro cultures, in contrast to the opposite effect of
other forms of stress (i.e., staurosporine and glutamate treat-
ment) which are able to induce a marked fragmentation of these
organelles. Interestingly, camptothecin-induced DNA damaging
in non-neuronal cell lines – such as ﬁbroblasts – does not evoke
any signiﬁcant mitochondrial elongation, providing the possible
existence of intrinsic cell-speciﬁc differences in biological response
of these organelles to exposure to similar stressor (Wang et al.,
2013). Noteworthy, more and more compelling evidence out-
lines an interesting role of Parkin in managing the mitochondrial
dynamics in response to insults of different severity. On one
hand, Parkin can exert adaptive effects upon damage of neu-
ronal mitochondria since, when these organelles are irreversibly
injured in response to severe stress, can promote their mitophagic
elimination mainly via K63-linked ubiquitination. On the other
hand, under a moderate insult conditions causing only minor
defects to these organelles, Parkin can support the maintenance
of their integrity by activating speciﬁc nuclear signaling pathway,
for instance the stimulation of their biogenesis (Shin et al., 2011)
via NF-κB-dependent transcription of reshaping OPA-1 protein
(Müller-Rischart et al., 2013). In the same way the long-term,
neuron-speciﬁc overexpression of Parkin can positively modulate
the mitochondrial dynamics/activity, likely by promoting their
biogenesis via the transcriptional co-activator PGC-1α, extending
thus the lifespan of the whole organism during the physiological
aging (Rana et al., 2013).
Another recently identiﬁed aspect of mitochondrial biology
regulated by the PINK1–Parkin pathway in neurons is the axonal
transport of these organelles (Wang et al., 2011; Liu et al., 2012b).
That a proper control in the functional connections between
mitochondrial ﬁssion–fusion dynamics and axonal transport is
critical for sustaining the neuronal survival has been largely doc-
umented (Frederick and Shaw, 2007; Saxton and Hollenbeck,
2012), as proved by the fact that inhibition of mitochondrial ﬁs-
sion protein Drp1 greatly reduces the number of these organelles
in synaptic terminals (Verstreken et al., 2005; Kageyama et al.,
2012). In fact, when Drp1 is deleted in post-mitotic neurons
such as in cerebellar PCs, mitochondria appear elongated like
swollen spheroids which accumulate oxidative damage, become
respiration-incompetent and co-localize with mitophagic markers
(i.e., LC3 and p62/sequestosome 1, p62/SQSTM1) and ubiqui-
tin. Interestingly the activity of Parkin appears dispensable for
mitochondrial ubiquitination in Drp1KO PCs, suggesting that
other E3 ubiquitin ligases may also operate in the quality con-
trol of neuronal mitochondria (Kageyama et al., 2012). Likewise,
the deﬁciency of Mfn2 in PCs also causes an anomalous devel-
opment/maturation of the dendritic arborization which exhibits
few spines generally lacking mitochondria which are, in contrast,
mainly distributed in cell body (Chen et al., 2007). Furthermore,
a large fraction of the mitochondrial mass resides in distal axons
and dendritic processes – far away from the soma where lyso-
somes are localized (Holtzman and Novikoff, 1965) – suggesting
thus that mitochondrial degradation in neurons is likely to require
a long-distance retrograde transport of these organelles toward
the cell body (Ashraﬁ and Schwarz, 2013). However, even if still
now it is not completely clear when malfunctioning mitochon-
dria are actually retrieved from axon, an engulfment of these
depolarized organelles has been also described to occur locally
in neurons within autophagosome before their transport to soma
(Wang et al., 2011). Additional supports in favor of a causal link
between mis-regulation of mitochondrial dynamics and neurode-
generation have been recently put forward by the ﬁnding that
the coordinated ability of the Pink1/Parkin pathway in immobi-
lizing unhealthy and faulty mitochondria prior their autophagic
elimination has been evolutionary conserved (Wang et al., 2011).
To this regard, in Drosophila motor neurons as well in primary
rodent hippocampal neurons, the overexpression of PINK1 or
Parkin causes a general decline of axonal motility of mitochon-
dria in association with the loss of Miro, a mitochondrial GTPase
interacting with the adapter protein Milton which, in turn, binds
the kinesin motor protein KIF5 (Hirokawa et al., 2010). Indeed,
upon PINK1 or Parkin overexpression or Parkin-induced recruit-
ment to mitochondria, Miro is ubiquitinated by Parkin and
targeted for proteasomal degradation so forcing the disassembly
of the Miro/Milton/kinesin complex which, in turn, quarantine
the movement of damaged mitochondria prior to their selective
clearance. The ability of PINK1/Parkin pathway in preventing
mitochondrial movement prior to their clearance is an impor-
tant step in assuring a proper quality control of these organelles
in neurons. In fact sequestration and/or eventual engulfment of
dysfunctional mitochondria would prevent their harmful accu-
mulation at high-energy demand regions of the neurites thus
(i) preventing further neuronal stress due to local ROS produc-
tion; (ii) enabling the intracellular pool of these organelles to
be replenished by healthier ones (Wang et al., 2011; Liu et al.,
2012b). Interestingly, the existence of an active Pink1–Parkin
pathway in primary neurons may reﬂect the exceptional chal-
lenges for neuronal populations in supplying their distal processes
with healthy mitochondria which locally provide sufﬁcient energy
and Ca+-buffering capacity needed for the synaptic transmis-
sion. At the same time, an active Pink1–Parkin pathway could
also explain why mutations in their genes are critically involved
in the etiology of PD affecting dopaminergic neurons of substan-
tia nigra, which show high rates of calcium inﬂux and a marked
susceptibility of dopamine oxidation (Surmeier et al., 2010). Alter-
natively, it is possible that the PINK1/Parkin pathway may also
regulate the mitochondrial transport through potential interac-
tion of Parkin with microtubules (Yang et al., 2005) or that the
lysosomal degradation could be completed outside the soma,
Frontiers in Aging Neuroscience www.frontiersin.org February 2014 | Volume 6 | Article 18 | 10
Amadoro et al. Mitophagy in post-mitotic neurons: the pink–parkin pathway
since mitochondrial markers have also been detected occasion-
ally in axonal autophagosomes (Maday et al., 2012). Remarkably,
it is particularly striking that Mfn2, a disease gene involved in
CMT neurodegeneration that is well known for having a key
role in Parkin-dependent mitophagy (Ziviani et al., 2010 ), facili-
tates the axonal transport of mitochondria in both directions by
forming a complex with Miro (Baloh et al., 2007; Misko et al.,
2010).
Finally, it has recently reported that the direct interaction
between endogenous Parkin and Ambra1, a positive regulator of
the Beclin-1-dependent autophagy (Fimia et al., 2007), enhances
the dynamics and efﬁciency of Parkin-dependent clearance of neu-
ronal mitochondria (Van Humbeeck et al., 2011), by stimulating
the peri-mitochondrial nucleation of new phagophores and their
consequent engulfment by autophagosomes. In details, endoge-
nous Parkin and Ambra1 coimmunoprecipitates from HEK293
cells, SH-SY5Y cells, and adult mouse brain and their interaction
is strongly increased during prolonged mitochondrial depolar-
ization; although there’s no clear evidence for ubiquitination of
Ambra1 by Parkin. Ambra1 is not required for Parkin translo-
cation to depolarized mitochondria but it critically contributes
to Parkin-mediated mitophagy, by locally stimulating the activ-
ity of the class III PI3K complex (Beclin-1, Vps34, p150, and
the autophagy-speciﬁc subunit Atg14) that is essential for the
formation of new phagophores (Tooze and Yoshimori, 2010).
Thus, Ambra1 recruitment to mito-aggresomes contributes to
the spatially restricted, selective nature of mitophagy, allowing
the controlled engulfment of dysfunctional mitochondria but
sparing the rest of the cell from unwanted autophagic degrada-
tion (Van Humbeeck et al., 2011). Interestingly, under normal
conditions, a pool of Ambra1 is docked by Bcl-2 at the mitochon-
dria, inhibiting its autophagic function. After induction of the
autophagy,mitochondrialAmbra1 is released fromBcl-2, enabling
it to bind to Beclin-1 in order to initiate the phagophore forma-
tion (nucleation) at the mitochondrion (Strappazzon et al., 2011).
However, whether Parkin and Ambra1 are degraded along with
the mitochondria or dissociate from mitochondria after setting
the mitophagic process, as well the detailed biochemical basis for
their increased binding upon mitochondrial depolarization, are all
important questions that remain to be still addressed.
DIFFERENT REGULATION OF MITOCHONDRIAL DYNAMICS
WITHIN SOMA AND NEURITIC PROCESSES IN NEURONS
A functional specialization into different sub-cellular compart-
ments occurs in post-mitotic neurons since axon and dendrites,
and not only the soma, exhibit unique biological and bioen-
ergetic needs such as localized synthesis and degradation of
proteins (Steward and Schuman, 2003; Piper and Holt, 2004).
Furthermore axon and dendrites have each one their own spe-
ciﬁc transport mechanisms (Hirokawa et al., 2010; Namba et al.,
2011), calcium regulation as well ER functions and localized ATP
requirement (Hollenbeck and Saxton, 2005; Mironov, 2009; Wang
and Schwarz, 2009; MacAskill and Kittler, 2010). Consequently,
the regulation of mitochondrial turnover is more complex in
neurons than in other mammalian non-neuronal cells because
it has to provide for different sub-cellular compartments and
locally regulate changeable concentrations of calcium and ADP
(MacAskill et al., 2009; Mironov, 2009; Hirokawa et al., 2010; Cai
et al., 2011; Figure 4). Synaptic activity (Rintoul et al., 2003; Sung
et al., 2008), the levels of nitric oxide (NO; Zanelli et al., 2006)
and calcium homeostasis, likely via the EF domains of Miro
which operates as calcium sensor (MacAskill et al., 2009; Wang
and Schwarz, 2009), tightly facilitate the trafﬁcking and recruit-
ment of neuronal mitochondria to high energy-demanding sub-
compartments, such as dendrites and terminal ﬁelds. In response
to the variable energy requirement of dendrites and axons, neu-
ronal mitochondria can be locally anchored by interacting with
neuroﬁlament and neuron-speciﬁc intermediate ﬁlaments (Toh
et al., 1980; Hirokawa and Takemura, 2005; Winter et al., 2008)
or with microtubules via syntaphilin anchor (Kang et al., 2008).
Interestingly, mitochondrial dynamics in axon and in distal den-
drites of healthy post-mitotic neurons are less frequent of that
observed in other non-neuronal cell or in cell bodies (Jendrach
et al., 2005; Berman et al., 2009). This conclusion is supported
by the fact that live-imaging quantiﬁcations show unexpectedly
that in primary cultured neurons the process of fusion occurs
in only 16% of mitochondria per hour in contrast to COS7
and INS1 cells where a ﬁssion event frequently occurs within
100 s after a coupled fusion (Twig et al., 2008). Furthermore, in
highly polarized neurons, the mitochondrial ﬁssion/fusion bal-
ance is singularly regulated in different sub-cellular compartments
depending on local energetic requirements in order to produce
mainly elongated organelles in the somatodendritic compart-
ment and more fragmented ones in distal axons (Overly et al.,
1996; Popov et al., 2005). For instance synaptic mitochondria,
which are localized at docking sites, signiﬁcantly differ from other
non-synaptic mitochondria as they are long-lived, undergo an
increased oxidation during aging (Vos et al., 2010; Du et al., 2012)
and contain higher levels of the matrix protein cyclophilin D
which makes them more susceptible to calcium insult (Brown
et al., 2006; Naga et al., 2007). These studies could also explain
why the selective vulnerability of synapses (“dying-back” degen-
eration) is an early prominent characteristic of many human
neurodegenerative disorders in which damage may begin at neu-
ron terminals in the absenceof any change in the cell body (Wishart
et al., 2006; Bettini et al., 2007). Importantly, synaptic mitochon-
dria are largely presynaptic (Gray and Whittaker, 1962; Nicholls,
1993) and residing mitochondria locally support the ATP syn-
thesis and Ca2+ buffering in addition to the neurotransmitter
synthesis and catabolism. Considering that (i) numerous neu-
rodegenerative diseases are characterized by iron accumulation
(Oshiro et al., 2011) which plays a crucial role in NMDA/NO-
mediated neurotoxicity (Cheah et al., 2006; Chen et al., 2013);
(ii) iron chelation is a strong Pink/parkin-independent activa-
tor of mitophagy (Allen et al., 2013), it has been proposed that
an umbalance in homeostasis of this ion might affect in neurons
the mitochondrial quality control processes (Allen et al., 2013).
Interestingly, using primary cortical neurons which are chroni-
cally exposed to non-lethal low-concentration of rotenone, it has
been proved that mitochondrial dynamics can be differentially
affected in neurons over time and in speciﬁc sub-cellular regions.
In fact, evidence outlines that the rates of ﬁssion and fusion of
these organelles can modify during the in vitro cultures matu-
ration (from 7 to 24 days of age) with changes which precede
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FIGURE 4 | Cartoon illustrating the mitochondrial turnover which copes
with the compartmentalized and distinct energetic requirements in the
cell body, axon, and synaptic compartments of post-mitotic neurons.
(A) In neurons, mitochondria travel long distances from the cell body out to
distal dendritic and axonal terminals, where they subserve the ATP production
and calcium homeostasis. The dynamic processes of biogenesis, fusion–
ﬁssion regulate the mitochondrial function and quality control, by allowing
them to adapt to spatial–temporal changes in cellular energy requirements.
Selective autophagy begins with the nucleation of an isolation membrane
(phagophore) which surrounds the damaged mitochondria to be degraded.
RER could serve as membrane donors for autophagosome formation and the
elongation of nascent double-membraned autophagic vesicle requires the
coordinated assembly of Atg12–Atg5–Atg16L complex and LC3–PE conju-
gates. (B) Newly formed autophagosomes move along microtubules in two
directions – as a result of the opposing activities of the minus-end-directed
motor protein dynein/dynactin and a plus-end-directed motor kinesin – and,
ﬁnally, concentrate in perinuclear region (close to centrosome) where fuse
with the lysosomes. Degradation of autophagosomal mitochondrial cargoes is
then achieved by the acid hydrolases and the cathepsin proteases that are
present in the lysosomal lumen.
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any sign of cell death, providing thus the existence of an impor-
tant temporal window for new therapeutic opportunities prior to
the onset of irreversible neurodegenerative phenomena. Besides,
compartments-speciﬁc compensatory changes (i.e., homeostatic
biogenesis) can be also possible in neurons in a attempt to bal-
ance the accumulating mitochondrial toxicity as demonstrated
by the ﬁnding that the density of these organelles increases in
more vulnerable and early affected distal neurites, prior to sig-
niﬁcant changes in cell bodies (Arnold et al., 2011). Furthermore,
the morphology and function of ER, which plays a key role in
mitochondrial ﬁssion (Friedman et al., 2011), may differ in soma-
todendritic compartment compared to distal axons (Ramírez and
Couve, 2011) and the specialized sub-cellular contacts between
ER and mitochondria [i.e., MAM (mitochondria-associated ER
membrane)] involved in lipid synthesis and Ca2+ handling are
also localized in hippocampal neurons at synapses to sustain
locally their integrative activities and integrity (Hedskog et al.,
2013). Finally, mitochondrial biogenesis occurs in neurons mainly
in the soma (Davis and Clayton, 1996; Saxton and Hollenbeck,
2012) and the activation of its regulatory nuclear transcrip-
tion factors – such as peroxisome proliferator-activated receptor
gamma coactivator 1α (PPARGC1A/PGC-1α) and NFR-1/2 is
controlled by neuronal activity (Yang et al., 2006; Scarpulla,
2008).
CONCLUSION
Neurons – as well other non-neuronal cellular types – appear to
be endowed by a common, basic molecular machinery involved in
selective elimination of damagedmitochondria via an autophagic-
lysosomal pathway named mitophagy. However, due to their
speciﬁc morphological and bioenergetic necessities, differentiated
neuronal populations display peculiar differences in mitophagic
processes compared to other replicating cells and, sometimes,
among the different brain regions. Increasing number of human
neurodegenerative disorders are causally linked to an impaired
mitochondrial turnover and two genes associated with autoso-
mal recessive forms of PD, PINK1 and Parkin, have been recently
found out to control the mitophagy also in primary post-mitotic
neurons. Thus, the understanding how these unique neuronal
features impinge on mitophagy and coordinated mitochondrial
biogenesis will help to develop new disease-modifying approaches
in future therapeutic interventions of neurodegenerative
diseases.
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